SINO UNIVERSAL PHARMACEUTICAL CO — Dapagliflozin Importer Profile
Pharmaceutical Importer · #5 buyer for Dapagliflozin · $1.7M import value · 36 shipments · CHINA · DGFT Verified
SINO UNIVERSAL PHARMACEUTICAL CO is the #5 importer of Dapagliflozin from India with $1.7M in import value and 36 verified shipments. SINO UNIVERSAL PHARMACEUTICAL CO holds a 2.9% market share in Dapagliflozin imports based in CHINA. The company sources from 1 verified supplier across 30 formulations shipped to 1 country.
SINO UNIVERSAL PHARMACEUTICAL CO — Dapagliflozin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Dapagliflozin to SINO UNIVERSAL PHARMACEUTICAL CO?
Verified from 36 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $1.7M | 36 | 100.0% |
SINO UNIVERSAL PHARMACEUTICAL CO sources Dapagliflozin from 1 verified Indian supplier based on 36 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does SINO UNIVERSAL PHARMACEUTICAL CO Compare to Nearest Dapagliflozin Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | AURO PHARMA INC | CANADA | $1.3M | 59 | $22.5K |
| 10 | JONAR TRANSPORT | ICELAND | $1.1M | 23 | $46.3K |
| 5 | SINO UNIVERSAL PHARMACEUTICAL CO ★ | CHINA | $950.0K | 19 | $50.0K |
| 9 | MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $950.0K | 19 | $50.0K |
| 12 | MANTRA DISTRIBUTIONS INC | CANADA | $850.9K | 19 | $44.8K |
SINO UNIVERSAL PHARMACEUTICAL CO ranks #5 among 502 Dapagliflozin importers from India. Average shipment value of $50.0K compared to the market average of $33.1K. The closest competitors by value are AURO PHARMA INC and JONAR TRANSPORT.
Where Does SINO UNIVERSAL PHARMACEUTICAL CO Import Dapagliflozin To?
Destination countries from 36 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CHINA | $1.7M | 36 | 100.0% |
SINO UNIVERSAL PHARMACEUTICAL CO imports Dapagliflozin to 1 country. The primary destination is CHINA receiving 100.0% of shipments worth $1.7M.
What Dapagliflozin Formulations Does SINO UNIVERSAL PHARMACEUTICAL CO Import?
| Formulation | Value | Shipments |
|---|---|---|
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10 MG)(30 TABLETS/BOTTLE) (20874 PACKS X1X30S= 626220 NOS) | $100.0K | 2 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10 MG) (20874 PACKx1x30'S=626220 NOS) | $100.0K | 2 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10MG)(30 TABLETS/BOTTLE) (20855 PACKS X 1X30'S=625650 NOS) | $100.0K | 2 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10MG)(30 TABLETS/BOTTLE) (20909 PACKS X 1X30'S=627270 NOS) | $100.0K | 2 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10MG)(30 TABLETS/BOTTLE) (21004 PACKS X 1X30'S=630120 NOS) | $100.0K | 2 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10MG)(30 TABLETS/BOTTLE) (21021 PACKS X 1X30'S=630630 NOS) | $100.0K | 2 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10MG)(30 TABLETS/BOTTLE) (1X30'Sx20874PACK=626220NUM) | $50.0K | 1 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10 MG)(30 TABLETS/BOTTLE) (20799 PACKS X1X30S=623970 NOS) | $50.0K | 1 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10 MG) (30 TABLETS/BOTTLE) (20931 PACKx1x30'S=627930 NOS) | $50.0K | 1 |
| DAPAQUIS (DAPAGLIFLOZIN TABLETS 10 MG) (30 TABLETS/BOTTLE) (20874 PACKx1x30'S=626220 NOS) | $50.0K | 1 |
SINO UNIVERSAL PHARMACEUTICAL CO imports 30 distinct Dapagliflozin formulations from India. The top formulation is DAPAQUIS (DAPAGLIFLOZIN TABLETS 10 MG)(30 TABLETS/BOTTLE) (2 with 2 shipments worth $100.0K.
Who Are the Top Buyers of Dapagliflozin from India and How Much Does SINO UNIVERSAL PHARMACEUTICAL CO Import?
India exported $16.6M worth of Dapagliflozin through 5,104 shipments from 254 suppliers to 113 countries, serving 502 buyers globally. SINO UNIVERSAL PHARMACEUTICAL CO imports $1.7M of this total, accounting for 2.9% of India's Dapagliflozin exports with 36 shipments from CHINA. This is verified from 36 customs shipment records covering 30 distinct formulations.
What Is the Average Order Value for SINO UNIVERSAL PHARMACEUTICAL CO's Dapagliflozin Imports?
SINO UNIVERSAL PHARMACEUTICAL CO's average Dapagliflozin order value is $47.1K per consignment, based on 36 shipments totaling $1.7M. SINO UNIVERSAL PHARMACEUTICAL CO is based in CHINA and ranks #5 among all Dapagliflozin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Dapagliflozin to SINO UNIVERSAL PHARMACEUTICAL CO?
SINO UNIVERSAL PHARMACEUTICAL CO sources Dapagliflozin from 1 verified Indian supplier: CIPLA LIMITED ($1.7M, 100.0%). This is based on 36 customs records.
How Does SINO UNIVERSAL PHARMACEUTICAL CO Compare to Other Dapagliflozin Importers?
SINO UNIVERSAL PHARMACEUTICAL CO ranks #5 among 502 Dapagliflozin importers from India with a 2.9% market share. The top 3 importers are AWAMEDICA ($3.0M), JAMP PHARMA CORPORATION ($2.3M), REGENCY PHARMA LIMITED ($1.3M). SINO UNIVERSAL PHARMACEUTICAL CO processed 36 shipments from CHINA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dapagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Dapagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SINO UNIVERSAL PHARMACEUTICAL CO matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SINO UNIVERSAL PHARMACEUTICAL CO's capped import value divided by total capped export value for Dapagliflozin across all Indian exporters.
- 5.Verified Records: This page is backed by 36 individual customs records matching SINO UNIVERSAL PHARMACEUTICAL CO importing Dapagliflozin, covering 30 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 113+ countries, 502+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Dapagliflozin Import Data for SINO UNIVERSAL PHARMACEUTICAL CO
Access order-level details, pricing data, supplier connections, and competitive analysis for SINO UNIVERSAL PHARMACEUTICAL CO's Dapagliflozin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SINO UNIVERSAL PHARMACEUTICAL CO
Company Profile
Multiple products · $0 total trade · Multiple categories
SINO UNIVERSAL PHARMACEUTICAL CO × Dapagliflozin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SINO UNIVERSAL PHARMACEUTICAL CO.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Dapagliflozin. For current order-level data, contact TransData Nexus.